Sentinel lymph node biopsy in squamous cell carcinoma of the head and neck: Where we stand now, and where we are going

Journal of Otolaryngology

Volumn 36, Issue 6, 2007, Pages 344-349

  Côté, Valérie ^a,b   Kost, Karen ^a,b   Payne, Richard J ^a,b   Hier, Michael P ^a  

^a MCGILL UNIVERSITY   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Elective neck dissection; Head and neck cancer; N0 neck; Sentinel lymph node; Sentinel lymph node biopsy; Squamous cell carcinoma

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; HEAD AND NECK CARCINOMA; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; NECK DISSECTION; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; SQUAMOUS CELL CARCINOMA; TREATMENT INDICATION;

CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; OROPHARYNGEAL NEOPLASMS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 38349178625     PISSN: 03816605     EISSN: None     Source Type: Journal    
DOI: 10.2310/7070.2007.0060     Document Type: Article

References (43)

1. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
2. Alex JC. The application of sentinel node radiolocalization to solid tumors of the head and neck: a 10-year experience. Laryngoscope 2004;114:2-19.
3. Chao C, Wong SL, Edwards MJ, et al. Sentinel lymph node biopsy for head and neck melanoma. Ann Surg Oncol 2003;10:21-6.
4. Pitman KT, Johnson JT, Brown ML, et al. Sentinel lymph node biopsy in head and neck squamous cell carcinoma. Laryngoscope 2002;112:2101-13.
5. Norman J, Cruse CW, Espinosa C, et al. Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma. Am J Surg 1991;162:432-7.
6. Uren RF. Lymphatic drainage of the skin. Ann Surg Oncol 2004;11:179S-85S.
7. Werner JA, Dünne AA, Folz BJ, et al. Value of sentinel lymphadenectomy in head and neck cancer. Ann Surg Oncol 2004;11:267S-70S.
8. Mozzillo N, Chiesa F, Caracò C, et al. Therapeutic implications of sentinel lymph node biopsy in the staging of oral cancer. Ann Surg Oncol 2004;11:263S-6S.
9. Werner JA, Dünne AA, Ramaswamy A, et al. The sentinel node concept in head and neck cancer: solution for the controversies in the N0 neck? Head Neck 2004;26:603-11.
10. Brobeil A, Cruse CW, Messina JL, et al. Cost analysis of sentinel lymph node biopsy as an alternative to elective lymph node dissection in patients with malignant melanoma. Surg Oncol Clin N Am 1999;8:435-45.
11. Ross GL, Shoaib T, Soutar DS, et al. The First International Conference on Sentinel Node Biopsy in Mucosal Head and Neck Cancer and adoption of a multicenter trial protocol. Ann Surg Oncol 2002;9:406-19.
12. Andersen PE, Cambroner E, Shaha AR, et al. The extent of neck disease after regional failure during observation of the N0 neck. Am J Surg 1996;172:686-91.
13. Righi PD, Kopecky KK, Caldemeyer KS, et al. Comparison of ultrasound-fine needle aspiration and computed tomography in patients undergoing elective neck dissection. Head Neck 1997;19:604-10.
14. Curtin HD, Ishwaran H, Mancuso AA, et al. Comparison of CT and MR imaging in staging of neck metastases. Radiology 1998;207:123-30.
15. Stern WB, Silver CE, Zeifer BA, et al. Computed tomography of the clinically negative neck. Head Neck 1990;12:109-13.
16. Friedman M, Mafee MF, Pacella BL Jr, et al. Rationale for elective neck dissection in 1990. Laryngoscope 1990;100:54-9.
17. Moreau P, Goffart Y, Collignon J. Computed tomography, pathologic comparative study. Arch Otolaryngol Head Neck Surg 1990;116:1190-3.
18. Van den Brekel MW, Castelijns JA, Stel HV, et al. Modern imaging techniques and ultrasound-guided aspiration cytology for the assessment of neck node metastases: a prospective comparative study. Eur Arch Otorhinolaryngol 1993;250:11-7.
19. Takes RP, Knegt P, Manni JJ, et al. Regional metastasis in head and neck squamous cell carcinoma: revised value of US with US-guided FNAB. Radiology 1996;198:819-23.
20. Hyde NC, Prvulovich E, Newman L, et al. A new approach to pre-treatment assessment of the N0 neck in oral squamous cell carcinoma: the role of sentinel node biopsy and positron emission tomography, 2003;39:350-60.
21. Kau RJ, Alexiou C, Laubenbacher C, et al. Lymph node detection of head and neck squamous cell carcinomas by positron emission tomography with flurorodeoxyglucose F 18 in a routine clinical setting. Arch Otolaryngol Head Neck Surg 1999;125:1322-8.
22. 18fluorodeoxyglucose positron emission tomography. Ann Surg 2000;231:229-34.
23. Alex JC, Krag DN. The gamma-probe-guided resection of radiolabeled primary lymph nodes. Surg Oncol Clin N Am 1996;5:33-41.
24. Ross GL, Soutar DS, Gordon MacDonald D, et al. Improved staging of cervical metastases in clinically node-negative patients with head and neck squamous cell carcinoma. Ann Surg Oncol 2004;11:213-8.
25. Pitman KT, Ferlito A, Devaney KO, et al. Sentinel lymph node biopsy in head and neck cancer. Oral Oncol 2003;39:343-9.
26. Ross GL, Soutar DS, Gordon MacDonald D, et al. Sentinel lymph node biopsy in head and neck cancer: preliminary results of a multicenter trial. Ann Surg Oncol 2004;11:690-6.
27. Höft S, Maune S, Muhle C, et al. Sentinel lymph-node biopsy in head and neck cancer. Br J Cancer 2004;91:124-8.
28. Ross G, Shoaib T, Soutar DS, et al. The use of sentinel node biopsy to upstage the clinically N0 neck in head and neck cancer. Arch Otolaryngol Head Neck Surg 2002;128:1287-91.
29. Werner JA, Dünne AA, Ramaswamy A, et al. Sentinel node detection in N0 cancer of the pharynx and larynx. Br J Cancer 2002;87:711-5.
30. White DC, Schuler FR, Pruitt SK, et al. Timing of sentinel lymph node mapping after lymphoscintigraphy. Surgery 1999;126:156-61.
31. Civantos FJ, Gomez C, Duque C, et al. Sentinel node biopsy in oral cavity cancer : correlation with PET scan and immunohistochemistry. Head Neck 2003;25:1-9.
32. Stoeckli SJ, Steinen H, Pfaltz, et al. Sentinel lymph node evaluation in squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 2001;125:221-6.
33. Pitman KT, Johnson JT, Edington H, et al. Lymphatic mapping with isosulfan blue dye in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1998;124:790-3.
34. Cimmino VM, Bown AC, Szocik JF, et al. Allergic reactions to isosulfan blue during sentinel node biopsy - a common event. Surgery 2001;130:439-42.
35. Plut EM, Hinkle GH, Guo W, et al. Kit formulation for the preparation of radioactive blue liposomes for sentinel node lymphoscintigraphy. J Pharm Sci 2002;91:1717-32.
36. Kontio R, Leivo I, Leppänen E, et al. Sentinel lymph node biopsy in oral cavity squamous cell carcinoma without clinically evident metastasis. Head Neck 2004;26:16-21.
37. Alex JC, Sasaki CT, Krag DN, et al. Sentinel lymph node radiolocalization in head and neck squamous cell carcinoma. Laryngoscope 2000;110:198-203.
38. Gershenwald JE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 1998;16:2253-60.
39. Cascinelli N, Belli F, Santinami M, et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO melanoma program experience. Ann Surg Oncol 2000;7:469-74.
40. Takeuchi H, Taback B, Kuo C, et al. Clinicopathological utility of molecular staging for melanoma patients undergoing sentinel lymphadenectomy. Ann Surg Oncol 2004;11:152S-5S.
41. Ferris RL, Xi L, Raja S, Hunt JL, et al. Molecular staging of cervical lymph nodes in squamous cell carcinoma of the head and neck. Cancer Res 2005;65:2147-56.
42. Godellas CV, Berman CG, Lyman G, et al. The identification and mapping of melanoma regional nodal metastases: minimally invasive surgery for the diagnosis of nodal metastases. Am Surg 1995;61:97-101.
43. Civantos F. Z0360A2 study synopsis. ACOSOG 2004;1-3.